New drug combo aims to stop aggressive breast cancer from coming back
NCT ID NCT05949021
Summary
This study is testing a combination of two chemotherapy drugs (liposomal doxorubicin and carboplatin) given after surgery for early-stage triple-negative breast cancer (TNBC). The main goal is to see if this treatment can lower the chance of the cancer returning. Researchers will also closely monitor side effects and test a new blood marker (ctDNA) to see if it can predict treatment success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER, TNBC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RWJBarnabas Health - Community Medical Center
Toms River, New Jersey, 08755, United States
-
RWJBarnabas Health - Monmouth Medical Center Southern Campus
Lakewood, New Jersey, 08701, United States
-
RWJBarnabas Health - Newark Beth Israel Medical Center
Newark, New Jersey, 07112, United States
-
RWJBarnabas Health - Robert Wood Johnson University Hospital
New Brunswick, New Jersey, 08903, United States
-
RWJBarnabas Health - Trinitas hospital and Comprehensive Center
Elizabeth, New Jersey, 08755, United States
-
RWJBarnabas Health Jersey City Medical Center
Jersey City, New Jersey, 07302, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
University Hospital-Newark
Newark, New Jersey, 07112, United States
Conditions
Explore the condition pages connected to this study.